🖥 Do you want to know more about the Long COVID Project? Which partners are involved in its #consortium? Are you interested in its main findings & progress? You can find this and further information on our #project #website: https://lnkd.in/eUgkPrME 📊 Project background, followed #methodology, its specific objectives, structure and consortium. 📰 News & events: updated section presenting all progress of the project but also #news, #events and relevant #publications related to #longcovid from external sources. 📚 Publications: Long COVID Project scientific articles & public deliverables. 👩🔬 Networking: relevant projects and initiatives related to #covid19 & #longcovid with whom the project is collaborating or will collaborate. 📝 Communication material: #newsletters, #pressreleases, project #flyer & #rollup, etc. #horizoneurope #covid19research #longcovid #postcovid #collaboration
Long COVID Project
Hospitals and Health Care
HE Project aiming to understand the mechanisms behind the long-term effects of a COVID-19 infection.
About us
Long COVID is a 48-month Horizon Europe project aiming to understand the mechanisms of host-virus response behind the long-term symptoms following COVID-19 infection. The number of patients suffering from long-term effects of a COVID-19 infection are growing worldwide. Based on different statistics, 1 in 10 patients is developing Long Covid Syndrome (LCS). Currently, there is no validated information on the underlying mechanism for LCS and validated therapeutic interventions are not available. It is therefore important to identify and understand the mechanisms behind the continuing symptoms and to use this improved understanding to provide adequate treatment to patients. This is what the Long COVID project aims to do. The project, coordinated by HUS Helsinki University Hospital (Finland) and including 12 partners from 6 countries (Finland, Germany, Netherlands, Italy, Estonia and Switzerland), will study the pathogenesis of LCS by: - conducting geographically diverse cohort and registry studies; - conducting mechanistic studies; - using novel high-throughput methods for biomarker analysis; - conducting interventional and follow-up studies on LCS patients. Imprint: Steinbeis 2i GmbH Steinhäuserstr. 12, 76135 Karlsruhe, Germany Phone: +49 721 93519 0 E-mail: info@steinbeis-europa.de Court registration: Stuttgart HRB 758508 VAT ID: DE308838809 This project has received funding from the European Union's Horizon Europe research and innovation programme under grant agreement No 101057553.
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- Helsinki
- Type
- Nonprofit
Locations
-
Primary
Get directions
Helsinki , FI
Updates
-
🌟 Exciting Announcement! 🌟 Get ready for an exciting event as the Long COVID Project welcomes you to an insightful Webinar! 🔓 "Unlocking the Mysteries of Long COVID: How EU Funding is Paving the Way for Recovery!" 🔑 When? 🗓️ Date: 29th May 2024 🕒 Time: 3pm to 4:30pm CEST 📍 Location: Online 🔗 Register here: https://lnkd.in/eBUbjS7c Stay tuned for a sneak peek at our session topics and meet the unique speakers from our consortium! Take this opportunity to gain invaluable insights. Don't miss out - register today! #LongCOVID #Webinar #Healthcare #COVID19
-
-
🌟 Happy Europe Day 2024! 🌟 Today marks the anniversary of the historic Schuman Declaration in 1950, a pivotal moment that laid the groundwork for the European Union as we know it. As we celebrate our shared values of unity, diversity and solidarity, let's also recognise the resilience of our European community in the face of challenges. We demonstrated this shared resilience not only during the COVID-19 pandemic. We are also working together to address the ongoing challenges of the pandemic and the long COVID. On Europe Day 2024, we want to raise awareness of the progress we have made together in tackling long COVID and highlight the research and knowledge that is still needed. Let's keep the momentum going to tackle the impact of the COVID-19 pandemic!
-
-
Discover insights on Long Covid and dive deeper and dive deeper in the incredible report "An incomplete picture: understanding the burden of long Covid" supported by Pfizer and created by Economist Impact. The report looks at the global and local impact of long Covid in eight focus countries, examining the societal, economic and health system implications. It assesses national agendas, policies and regional health strategies, emphasising the need for holistic, patient-centred care and coherent policy frameworks to effectively address the challenges of long Covid. With diverse manifestations and significant global challenges, it's crucial to understand and address its multifaceted burdens. Learn about emerging best practices for holistic care and support in the report! 👇 https://lnkd.in/e9AurwyC
-
🌟 It's #WorldImmunizationWeek! 🌟 The COVID-19 pandemic has marked the beginning of a new era for vaccines & immunization and has taught us the vital role vaccines play in protecting our health. No one should suffer from a disease we know how to prevent. It's #HumanlyPossible!🌍💉
-
-
📢 Webinar recommendation! Don't miss the next World Health Organization webinar on post COVID-19 conditions organised by Project ECHO on Wednesday (24 April) and Friday (26 April) this week! Learn more about Postural Orthostatic Tachycardia Syndrome (POTS) in post COVID-19 condition. Join the webinar and hear more from experts on how to recognise and diagnose POTS and how to support patients manage their symptoms. https://lnkd.in/gShdXGi9
Check out our next WHO webinar on Post COVID19 condition. We will go deep dive into POTS. Wed, April 24 and Fri, Apr 26 Postural Orthostatic Tachycardia Syndrome (POTS) has emerged as a common presentation in post COVID-19 condition. Hear from experts how to recognize and diagnose POTS, and support patients in managing symptoms. Register here: https://lnkd.in/e6vS9s4J #longcovid #postcovid #postcovid19condition #postcovidcondition #covid19 #coronavirus #dysautonomia #WHO #healthcare #clincalcare Jamie Rylance Steve McGloughlin Maria Van Kerkhove
iECHO | All Teach, All Learn
iecho.org
-
On Tuesday, once again, experts and those affected gathered together for the 3rd Long Covid Roundtable in Berlin to discuss the latest research and treatment options. The German Health Minister Karl Lauterbach said: "Germany is currently at a turning point with Long COVID." He announced that research funding programmes totalling 150 million euros are now underway. Goals have been set for improved networking between experts, better care and support for children and young people, and more. "We will not abandon the victims of LongCovid!" To all the German speakers: More information in the video 👇
„Deutschland steht derzeit an einem Wendepunkt bei Long COVID“, sagte Bundesgesundheitsminister Prof. Karl Lauterbach am Dienstag im Anschluss an den 3. Runden Tisch Long COVID in Berlin. Erneut tauschten sich Expertinnen und Experten mit Betroffenen zur aktuellen Forschung und Behandlungsmöglichkeiten aus. Durch eine stärkere Vernetzung von Expertinnen und Experten, mehr Fördermittel und die Behandlung mit bereits für andere Indikationen zugelassenen Medikamenten schaffe man eine deutliche Verbesserung der Versorgung von Long-COVID-Betroffenen, so Lauterbach. Mehr dazu im Video 👇 #LongCOVID #RunderTisch #MECFS #Forschung
-
📚 Don’t miss the remarkable letter, which recently has been published in the Nature Immunology Journal by Liew et. al. ❓About 1 in 10 people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) experience prolonged symptoms known as long COVID. However, the different types of the disease and their underlying mechanisms are not fully understood yet. The researchers profiled 368 plasma proteins in 657 individuals who had been hospitalised for at least 3 months. Among them, 426 had ongoing long COVID symptoms while 233 had fully recovered. „Our study aimed to understand inflammatory processes that underlie long COVID and was not designed for biomarker discovery. Our findings suggest that specific inflammatory pathways related to tissue damage are implicated in subtypes of long COVID, which might be targeted in future therapeutic trials.“ (Liew et al., 2024)
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease - Nature Immunology
nature.com
-
📢 Exciting News! 🚨 The Long COVID Project just launched its 4th Press Release! In this Press Release, the #LongCovid project celebrates its half-time milestone and presents an overview of the published scientific papers generated by the project so far. These articles present the results of different studies. Do not miss it! 👇 https://lnkd.in/ejCnvzKw
4th Long COVID Press Release
https://longcovidproject.eu
-
📚 Don’t miss the insightful research article published in the Nature Communications Journal by Rob Wüst. In a longitudinal case-control study (NCT05225688), Wüst and colleagues gained new insights into the pathophysiology of post-exertional malaise in people with long COVID. In this study, the researchers examined 23 patients with long COVID and 21 people from the control group. In addition to several examinations and blood tests, they took muscle biopsies at different time points to measure skeletal muscle abnormalities. Gain more insights into this research article and read the full article. 👇 https://lnkd.in/esRy-jRa
Muscle abnormalities worsen after post-exertional malaise in long COVID - Nature Communications
nature.com